COMPOUNDING
This simple, easily modifiable preparation is useful for treating skin
dryness or irritation brought on by low-humidity indoor settings.
Some corticosteroid-responsive skin disorders may be treated with this topical preparation.
A liquid version of this influenza medication may be easily prepared using the capsule formulation.
In lozenge form, this analgesic and anesthetic agent can be prepared to suit the patient's individual flavor preference.
Pain and inflammatory conditions of the oral cavity may be relieved with this preparation.
The key ingredient in this compound is used for the alleviation of minor skin irritations and disorders.
Swimmer's ear, a common summertime ailment, may be treated with this antibiotic preparation.
Treatment with this preparation may minimize the progression of skin
damage from actinic keratoses and help prevent skin cancers from
developing.
The FDA's position seems to cast aspersions on the entire compounding community.
This preparation can be applied to the surface of open ulcers and wounds.
This high-risk compound, which is used to relieve pain and
inflammation, should be prepared according to stringent aseptic
methods.
This preparation can be used for the relief of nausea and vomiting associated with chemotherapy, radiation, or surgery.
This form of delivery is effective because it remains longer on the diseased area compared with rinses.
This preparation can be used in patients who have difficulty swallowing pills or in those for whom other administration routes are not desirable.
Psoriasis and other chronic skin conditions responsive to the primary ingredient may be treated with this preparation.
In unrelated cases that received widespread attention a few years ago, two college-aged women died after applying a pharmacy-compounded combination of lidocaine and tetracaine topical gel.